METABOLITE TECHNOLOGY


R&D History

With know-how accumulated through many years of microorganism cultivation Fugenbio is actively engaging in commercialization of an extract of the culture medium and the research focused on indications

Specifying fungiosis (2010)

- Screening of multiple kinds of mushroom mycelium which were verified to be effective at anti-cancer and anti-diabetes
- Found Ceriporia lacerata in the process of researching the functionality of Ganoderma applanatum mycelium

Fundamental Research Performance (2013)

- Spawn stabilization through subculture
- Establishment of optimal liquid culture conditions
- Research on Ceriporia lacerata as diabetes medicine
- Effective substance test, Efficacy evaluation(in vitro, in vivo, clinical trial), Toxicity evaluation (GLP institution)

Clinical trial progress (2015)

- Verified improvements in blood pressure, liver function, and hyperlipidemia (complex function)
- Evaluation of skin safety and clinical efficacy
- Performance of national projects; publication of theses in main journals; security of patents

Developing new drug materials, improving cognitive skills (2017)

.

Industrialization of material (2019)

- Processed the certification of KFDA Health Functional Food Product and of FDA NDI
- Commercialization of functional cosmetic raw substance
- Research on bio medical products, including diabetes medicine

Specifying fungiosis (2010)

- Screening of multiple kinds of mushroom mycelium which were verified to be effective at anti-cancer and anti-diabetes
- Found Ceriporia lacerata in the process of researching the functionality of Ganoderma applanatum mycelium

Fundamental Research Performance (2013)

- Spawn stabilization through subculture
- Establishment of optimal liquid culture conditions
- Research on Ceriporia lacerata as diabetes medicine
- Effective substance test, Efficacy evaluation(in vitro, in vivo, clinical trial), Toxicity evaluation (GLP institution)

Clinical trial progress (2015)

- Verified improvements in blood pressure, liver function, and hyperlipidemia (complex function)
- Evaluation of skin safety and clinical efficacy
- Performance of national projects; publication of theses in main journals; security of patents

Developing new drug materials, improving cognitive skills (2017)

.

Industrialization of material (2019)

- Processed the certification of KFDA Health Functional Food Product and of FDA NDI
- Commercialization of functional cosmetic raw substance
- Research on bio medical products, including diabetes medicine